Physician profile
Charles Nutting
NPI 1063459691
$1,087,351.77
in general payments reported to CMS, 2019-2025
34 companies · $36K in 2025
The $36K reported for 2025 was more than what 96% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $686K · 2021: $113K · 2022: $45K · 2023: $82K · 2024: $78K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $113K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Acquisitions: $21K · Travel and Lodging: $8,126 · Food and Beverage: $4,286 · Honoraria: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $113,229.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,840.00 |
| Acquisitions | $20,684.06 |
| Travel and Lodging | $8,126.43 |
| Food and Beverage | $4,286.00 |
| Honoraria | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $626,194.44 | 2019-2020 | |
| Medtronic, INC. | $104,043.20 | 2021-2025 | Ellipsys Vascular Access System, Abre, Concertotm |
| Ge Healthcare | $87,333.85 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $81,141.08 | 2021-2025 | Embozene |
| Sirtex Medical INC | $57,694.89 | 2019-2025 | Sir-Spheres Microspheres |
| Merit Medical Systems INC | $48,231.16 | 2019-2025 | Embosphere Microspheres, Swiftninja Sterble Cor Micro, Microsphere Embospheres |
| Angiodynamics, INC. | $39,557.48 | 2019-2023 | Auryon Laser System 100-120 Vac |
| Varian Medical Systems, INC. | $13,446.20 | 2019-2021 | |
| Trisalus Life Sciences, INC. | $8,190.54 | 2020-2025 | Trinav Infusion System |
| Abk Biomedical USA, INC. | $7,184.53 | 2023-2025 | Eye90 Microspheres, Easi-Vue Embolic Microspheres System |
| Biocompatibles Uk Ltd | $6,480.00 | 2019 | |
| Boston Scientific Corporation | $6,415.17 | 2019-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, General - Interventional Oncology, Varithena Administration Pack |
| Abbott Laboratories | $228.30 | 2019-2020 | |
| Asahi Intecc USA, INC. | $208.79 | 2023-2025 | Asahi Ptca Guide Wire, Asahi Peripheral Vascular Wires |
| Philips North America LLC | $129.61 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mediview Xr, INC. | $126.56 | 2024 | |
| Ethicon INC. | $104.43 | 2021 | |
| Tersera Therapeutics LLC | $101.89 | 2024-2025 | Xermelo, Zoladex |
| W. L. Gore & Associates, INC. | $100.63 | 2021-2022 | |
| Biocompatibles, INC. | $86.61 | 2019 | |
| Cook Medical LLC | $57.07 | 2020-2025 | Torcon Nb |
| Organogenesis INC. | $48.71 | 2021 | |
| Stryker Corporation | $46.98 | 2021-2022 | |
| Terumo Medical Corporation | $42.08 | 2025 | Navicross, Angio-Seal, Azur Cx Detachable |
| Histosonics, INC. | $36.68 | 2025 | |
| Veryan Medical Incorporated | $26.69 | 2022 | |
| Cardiovascular Systems INC. | $18.20 | 2019 | |
| Smith+Nephew, INC. | $16.72 | 2020 | |
| Recordati_rare_diseases_inc. | $16.31 | 2025 | Isturisa |
| Bard Peripheral Vascular, INC. | $14.93 | 2020 | |
| Depuy Synthes Sales INC. | $14.87 | 2019 | |
| Medtronic USA, INC. | $13.17 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$82,720.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Nutting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.